Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 1/20 | 0.62 |
| ▸ | MPO | P05164 | 5/20 | 0.49 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.49 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.48 |
| ▸ | HSPA5 | P11021 | 1/20 | 0.45 |
| ▸ | CA12 | O43570 | 4/20 | 0.44 |
| ▸ | CA2 | P00918 | 4/20 | 0.44 |
| ▸ | CA9 | Q16790 | 4/20 | 0.44 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.41 |
| ▸ | HTR1A | P08908 | 1/20 | 0.41 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29194866 | 0.94 | MGLL (0.70) | MGLLMPOSLC6A4TAAR1HSPA5 | |
| SCHEMBL10881485 | 0.93 | MGLL (0.73) | MGLLMPOSLC6A4TAAR1HSPA5 | |
| SCHEMBL10976350 | 0.88 | MGLL (0.56) | MGLLMPOSLC6A4TAAR1HSPA5 | |
| SCHEMBL25437680 | 0.85 | MGLL (0.62) | MGLLMPOSLC6A4TAAR1HSPA5 | |
| SCHEMBL9647433 | 0.82 | MGLL (0.59) | MGLLTSHRKDM4EHSD17B10 | |
| Sulfuric Acid SCHEMBL5433107 | 0.79 | MGLL (0.56) | MGLLMPOSLC6A4TAAR1TSHR | |
| SCHEMBL7996177 | 0.79 | MGLL (0.75) | MGLLMPOSLC6A4TAAR1HSPA5 | |
| SCHEMBL11285123 | 0.79 | MGLL (0.40) | MGLLCA12CA2CA9CYP2D6 | |
| SCHEMBL4967651 | 0.79 | TAAR1 (0.65) | MGLLMPOSLC6A4TAAR1HSPA5 | |
| SCHEMBL3800530 | 0.79 | TAAR1 (0.65) | MGLLMPOSLC6A4TAAR1HSPA5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107580615-A | Store stable impregnating resin and electrical insulation tape | 西门子公司 | 2018-01-12 | — | — | CN | claimed |
| US-11535647-B2 | Peptide purification method using sulfonate compound | NAGASE & CO., LTD. (JP) | 2022-12-27 | — | — | US | disclosed |
| US-20220144888-A1 | PEPTIDE PURIFICATION METHOD USING SULFONATE COMPOUND | NAGASE & CO., LTD. (JP) | 2022-05-12 | — | — | US | disclosed |
| EP-3851446-A1 | PEPTIDE PURIFICATION METHOD USING SULFONATE COMPOUND | Nagase & Co., Ltd. (JP) | 2021-07-21 | — | — | EP | disclosed |
| WO-2020054287-A1 | PEPTIDE PURIFICATION METHOD USING SULFONATE COMPOUND | 長瀬産業株式会社 | 2020-03-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220144888-A1 | PEPTIDE PURIFICATION METHOD USING SULFONATE COMPOUND | VIP, IAPP, RPS27A | MGLL 2420/4885MPO 3200/4885SLC6A4 2177/4885 |
| US-11535647-B2 | Peptide purification method using sulfonate compound | VIP, IAPP, RPS27A | MGLL 2420/4885MPO 3200/4885SLC6A4 2177/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.